Amgen Inc (AMGN)

Exchange
NASDAQ
Symbol
AMGN
Sector
Healthcare
Industry
Drug Manufacturers - General
Description
Amgen Inc. is a leading multinational biopharmaceutical company headquartered in Thousand Oaks, California, recognized for its pioneering therapies developed through recombinant DNA technology. The company focuses on key therapeutic areas including oncology, nephrology, and inflammation, utilizing its deep expertise in molecular biology to create and commercialize innovative biologic products that significantly improve patient outcomes. With a comprehensive drug pipeline and a strong foothold in the biotechnology landscape, Amgen is dedicated to addressing global unmet medical needs while striving to enhance the quality of life for patients across the globe. Its commitment to research and development positions Amgen as a critical player in advancing medical science and improving health outcomes worldwide.
Country
USA

Stock price

At close: February 12, 2026

  • Open
    366.66
  • High
    370.88
  • Low
    365.06
  • Close
    366.20
  • Volume
    2,374,460

Financial ratios

Dec 31, 2025